Breaking News Instant updates and real-time market news.

FB

Facebook

$177.10

-0.98 (-0.55%)

11:45
06/12/19
06/12
11:45
06/12/19
11:45

Emails could show Zuckerberg knew of questionable privacy practices, WSJ says

Facebook uncovered emails that appear to show CEO Mark Zuckerberg's connection to potentially problematic privacy practices at the company, The Wall Street Journal's John McKinnon, Emily Glazer, Deepa Seetharaman and Jeff Horwitz report, citing people familiar with the matter. Within the company, the unearthing of the emails in the process of responding to a continuing federal privacy investigation has raised concerns that they would be harmful to Facebook if they were to become public, a source said. Reference Link

  • 10

    Jul

FB Facebook
$177.10

-0.98 (-0.55%)

06/04/19
BARD
06/04/19
NO CHANGE
BARD
Risk of large-cap tech breakups 'fairly low,' says Baird
Following yesterday's multiple media reports that antitrust regulators were laying out their lines of responsibility if they choose to pursue investigations of Google (GOOGL), Amazon (AMZN), Facebook (FB) and Apple (AAPL), Baird analyst Colin Sebastian said he views the odds of "nuclear options," such as forced breakups of Google, Facebook or Amazon, as "fairly low." However, he sees the chances of anti-trust action short of breakups as "moderate" and thinks the odds of regulation around privacy and security are "relatively high." Sebastian thinks Amazon and Alibaba (BABA) could outperform other large-cap tech stocks amid the "specter of government intervention," though he also thinks positive revenue trends at Facebook could lead to a rebound after investors digest the current news.
06/04/19
RAJA
06/04/19
NO CHANGE
RAJA
Google has most antitrust risk, but still a buy on pullback, says Raymond James
Raymond James analyst Aaron Kessler noted that Alphabet (GOOG) shares fell 6%, Facebook (FB) declined over 7%, and Amazon (AMZN) dropped nearly 5% on Monday due to concerns around investigations from the Department of Justice and FTC and news after the close that House Antitrust Subcommittee Chairman David Cicilline announced a bipartisan investigation into competition in digital markets. While he believes Google has the most antitrust risk among the group given the history of fines by the European Commission, Kessler also noted that European fines have been relatively immaterial to Google's market cap and fundamentals. He views the pullback as a buying opportunity given that core fundamentals remain solid for Google, Facebook, and Amazon, calling the valuations of Alphabet and Facebook "particularly" attractive.
06/11/19
MOFT
06/11/19
UPGRADE
Target $210
MOFT
Buy
Facebook upgraded to Buy from Neutral at MoffettNathanson
MoffettNathanson analyst Michael Nathanson upgraded Facebook to Buy from Neutral with a $210 price target.
06/11/19
06/11/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Facebook (FB) upgraded to Buy from Neutral at MoffettNathanson. 2. Red Rock Resorts (RRR) upgraded to Buy from Neutral at Goldman Sachs with analyst Stephen Grambling saying he sees 35% total return potential in the stock as he believes a successful Palms ramp and free cash flow "inflection" in 2020 can drive a "sustained re-rating." 3. JetBlue (JBLU) upgraded to Buy from Neutral at Citi with analyst Kevin Crissey saying JetBlue has positive catalysts to support incremental buyers with a range of time horizons and investment styles. 4. Lyft (LYFT) upgraded to Positive from Neutral at Susquehanna. 5. Dollar Tree (DLTR) resumed with an Overweight from Neutral at JPMorgan with analyst Matthew Boss saying he expects an inflection to high-single net income growth and low-double-digit consolidated earnings growth beyond fiscal 2019 as the Dollar Tree offers stability and Family Dollar improves. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

KTOS

Kratos Defense

$22.20

0.35 (1.60%)

08:22
06/27/19
06/27
08:22
06/27/19
08:22
Hot Stocks
Kratos Defense receives $4.1M C5ISR system contract award »

Kratos Defense &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRCA

Verrica Pharmaceuticals

08:22
06/27/19
06/27
08:22
06/27/19
08:22
Recommendations
Verrica Pharmaceuticals analyst commentary  »

Verrica reported positive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DLPH

Delphi Technologies

$19.23

0.67 (3.61%)

08:21
06/27/19
06/27
08:21
06/27/19
08:21
Initiation
Delphi Technologies initiated  »

Credit Suisse sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETTX

Entasis Therapeutics

$6.23

0.04 (0.65%)

08:21
06/27/19
06/27
08:21
06/27/19
08:21
Hot Stocks
Entasis Therapeutics announces new results on antimicrobial programs »

Entasis Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJT

DJ Transportation Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

$0.00

(0.00%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$183.53

1.54 (0.85%)

08:20
06/27/19
06/27
08:20
06/27/19
08:20
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$77.84

0.82 (1.06%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$63.46

0.99 (1.58%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BWA

BorgWarner

$41.55

0.05 (0.12%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Initiation
BorgWarner initiated  »

Credit Suisse bullish on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

XLY

Consumer Discretionary Sector SPDR

$118.12

0.35 (0.30%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLB

S&P Select Materials SPDR

$57.80

-0.12 (-0.21%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADAP

Adaptimmune

$4.07

0.07 (1.75%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Hot Stocks
Adaptimmune CFO Adrian Rawcliffe to succeed James Noble as CEO »

Adaptimmune Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

BC

Brunswick

$45.29

0.2 (0.44%)

08:19
06/27/19
06/27
08:19
06/27/19
08:19
Downgrade
Brunswick rating change  »

Brunswick downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$59.33

-1.3 (-2.14%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOVA

Dova Pharmaceuticals

$10.56

0.27 (2.62%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Conference/Events
Dova Pharmaceuticals to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

XLP

Consumer Staples Sector SPDR

$57.99

-0.82 (-1.39%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$91.62

-1.23 (-1.32%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$150.83

-0.31 (-0.21%)

08:18
06/27/19
06/27
08:18
06/27/19
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$265.29

0.03 (0.01%)

08:17
06/27/19
06/27
08:17
06/27/19
08:17
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRV

ContraVir Pharmaceuticals

$4.09

-0.485 (-10.61%)

08:17
06/27/19
06/27
08:17
06/27/19
08:17
Hot Stocks
ContraVir Pharmaceuticals submits IND application for CRV431 »

ContraVir Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$290.48

-0.32 (-0.11%)

08:17
06/27/19
06/27
08:17
06/27/19
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$26.97

-0.05 (-0.19%)

08:17
06/27/19
06/27
08:17
06/27/19
08:17
Technical Analysis
Financial Select Sector: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMH

Market Vectors Semiconductor

$108.66

3.2 (3.03%)

08:16
06/27/19
06/27
08:16
06/27/19
08:16
Technical Analysis
Market Vectors Semiconductor: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.